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Cys-loop receptorThe α4β2 nicotinic acetylcholine receptor (nAChR) is the predominant heteromeric subtype of nAChRs in
the brain, which has been implicated in numerous neurological conditions. The structural information specif-
ically for the α4β2 and other neuronal nAChRs is presently limited. In this study, we determined structures of
the transmembrane (TM) domains of the α4 and β2 subunits in lauryldimethylamine-oxide (LDAO) micelles
using solution NMR spectroscopy. NMR experiments and size exclusion chromatography-multi-angle light
scattering (SEC-MALS) analysis demonstrated that the TM domains of α4 and β2 interacted with each
other and spontaneously formed pentameric assemblies in the LDAO micelles. The Na+ ﬂux assay revealed
that α4β2 formed Na+ permeable channels in lipid vesicles. Efﬂux of Na+ through the α4β2 channels
reduced intra-vesicle Sodium Green™ ﬂuorescence in a time-dependent manner that was not observed in
vesicles without incorporating α4β2. The study provides structural insight into the TM domains of the
α4β2 nAChR. It offers a valuable structural framework for rationalizing extensive biochemical data collected
previously on the α4β2 nAChR and for designing new therapeutic modulators.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The nicotinic acetylcholine receptor (nAChR) is a member of the
Cys-loop superfamily that mediates fast synaptic transmission in
the central and peripheral nervous systems. The α4β2 nAChR is the
most abundant heteromeric nAChR subtype in the brain [1]. It has
been implicated to play roles in Parkinson's disease [2], Alzheimer's
disease [3], nicotine addiction [4,5], and general anesthesia [6–8].
Despite the importance of the α4β2 nAChR in various neurological
conditions, experimental structural characterization of the α4β2
nAChR remains sparse [9–11]. Structural understanding of nAChRs
has relied heavily on the cryo-electron microscopy structural model
of the muscle type nAChR found in the electric ray Torpedo marmorata
[12]. The structural model has only a resolution of 4 Å, but shows a
pentameric scaffold and extracellular (EC), transmembrane (TM), and
intracellular (IC) domains for each of the ﬁve subunits. More recently,
homologous structures of the bacteria Gloebacter violaceous (GLIC)
[13,14] and Erwinia chrysanthemi (ELIC) [15] and the Caenorhabditis
elegans glutamate-gated chloride channel alpha (GluCl) [16] have
been determined at resolutions of 2.9 Å, 3.3 Å, and 3.3 Å, respectively.
Unlike mammalian Cys-loop receptors, GLIC and ELIC do not contain aTower 3, 3501 Fifth Avenue,
l.: +1 412 383 9798; fax: +1
rights reserved.large IC domain. Among the EC, TM and IC domains of Cys-loop recep-
tors, the EC domain containing the orthosteric agonist-binding site has
the richest structural information, mainly from crystal structures of
the acetylcholine binding protein (AChBPs) [17–19], the EC domain of
the mouse α1 subunit [20], and the chimera of the α7 nAChR-AChBP
[21]. In contrast, the IC domain connecting TM3 and TM4 is the least
studied domain. This domain is the least conserved among nAChR
subunits and has the least structural data at present. The IC domain is
known to modulate interaction with cytoskeleton components as well
as channel desensitization [22]. However, it was demonstrated that
fully functional channels could be obtained by replacing the IC domain
with a short linker found in GLIC [23].
Although structural understanding of the TM domain is not as
inadequate as that on the IC domain, more thorough structural char-
acterizations on the TM domain for individual Cys-loop receptors are
required in order to satisfy the demands for rational design of thera-
peutic drugs and for discovery of molecular mechanisms of drug
action [24,25]. The TM domain contains the channel gate. Hence,
it is the critical region for controlling the ﬂow of ions across the
membrane [26]. Positive and negative allosteric modulators acting
at the TM domains of nAChRs [27–29] have been implicated as useful
therapeutics for neurological diseases. The TM domain also provides
binding sites for general anesthetics. The intravenous anesthetic
etomidate binds to the TM domain of the Torpedo nAChR [30]. The
inhalational anesthetic halothane shows binding to the TM domain
both experimentally in the Torpedo nAChR [31] and computationally
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mation of nAChR TM domains is therefore important both for charac-
terizing mechanisms of action for existing drugs and identifying
plausible binding sites for new drugs.
While the interplay between the EC and TM domains is critical for
transducing ligand-binding signals to the channel gate, the intrinsic
folding of the TM domain seems to be independent of the existence
of the EC domain. Incorporation of the TM2 helix into a lipid environ-
ment was found to produce ion speciﬁc channels [35,36]. Further-
more, we have previously demonstrated faithful folding of the TM
domain of the β2 subunit in membrane mimetic microclusters formed
by a hexaﬂuoroisopropanol and water mixture (1:1) [9]. Thus, it is
reasonable and practical to solve structures of the TM domains in the
absence of the EC and IC domains.
In the present study, we used lauryldimethylamine-oxide (LDAO)
micelles as a membrane mimetic and solved the NMR structures for
the TM domains of the α4 and β2 nAChR subunits. We found that
the α4 and β2 TM domains form pentameric assemblies in LDAO
micelles. When reconstituted into lipid vesicles, the α4β2 assemblies
are capable of transporting Na+ ions. High-resolution structures of
the individual α4 and β2 TM domains and the assembled pentameric
structural model for the α4β2 nAChR TM domain provide valuable
templates for understanding mechanisms of channel function and
drug action as well as for rational drug discoveries.
2. Materials and methods
2.1. Sample preparations
The method to obtain the α4 and β2 TM domains of the human
nAChR was reported previously [9]. Proteins were expressed in
E. coli Rosetta 2(DE3) pLysS (Novagen) at 15 °C for ~3 days using
the Marley protocol [37]. The EC domain at the N-terminus was
replaced with a TEV protease recognition site and a histidine tag. A
short synthetic linker of ﬁve glycines replaced the IC domain. Each
α4 or β2 TM domain contains 137 residues with an approximate
molecular weight of 15 kDa. Glutamate mutations at the N- and C-
termini, designed to lower the pI, were necessary to secure protein
stability for NMR measurements. Mutation of three hydrophobic
residues to serine within the TM2–TM3 linker of α4 or β2 was also
instrumental to prevent protein destabilization. Direct exposure of
hydrophobic residues to the aqueous phase in the absence of the EC
domain resulted in protein precipitation in a short time period.
Amino acid sequences showing mutations of the α4 and β2 TM
domains are provided in the Supplementary Material (Fig. S1). The
expressed proteins were puriﬁed by Ni-NTA (GE Healthcare) chroma-
tography before and after overnight cleavage of the his-tagged region
at 4 °C. The puriﬁcation buffer contained 50 mMTris, 150 mMNaCl, and
0.5% LDAO, and proteins were eluted with imidazole. Each NMR sample
had 0.25–0.3 mM protein, 1–2% (40–80 mM) LDAO, 5 mM phosphate
acetate pH 4.7, 10 mMNaCl, and 20 mM 2-mercaptoethanol to prevent
disulﬁde bond formation. 5% D2O was added to the NMR samples
for deuterium lock in NMR measurements. In terms of the α4 and β2
contents, we prepared four types of samples: (1) pure α4; (2) pure
β2; (3) α4:β2=2:3; and (4) α4:β2=3:2.
2.2. NMR spectroscopy
NMR spectra were acquired at 45 °C on Bruker Avance 600, 700,
800, and 900 MHz spectrometers equipped with a triple-resonance
inverse-detection cryoprobe, TCI (Bruker Instruments, Billerica, MA).
Spectral windows of 11 or 13 ppm (1024 data points) in the 1H
dimension and 22 or 24 ppm (128 data points) in 15N dimension
with a relaxation delay of 1 s (or 1.5 s at 900 MHz) were used for
collecting 1H–15N TROSY–HSQC spectra. 1H–13C HSQC spectra were
acquired as 1024 points in the 1H dimension and 256 increments inthe 13C dimension with spectral windows of 11 ppm (1H) and 64 ppm
(13C). For chemical shift assignment, we performed a suite of 3D
experiments, including HNCA and HN(CO)CA (1024×36×80, 600 or
700 MHz) with a spectral window of 18 ppm in the 13C dimension,
HNCO (1024×36×40, 600 or 700 MHz) with a 13C spectral width of
10 ppm, 15N-edited NOESY (1024×36×160) with a mixing time of
120 ms at 900 MHz and 150 ms at 700 MHz, and 13C-edited NOESY
(1024×36×192, 700 MHz) with a mixing time of 150 ms. In addition,
CBCA(CO)NH (1024×32×80, 700 MHz) with a 13C spectral window
of 60 ppmwas acquired forα4. In order to evaluate the temperature de-
pendence of individual residue chemical shifts, α4 and β2 1H–15N
TROSY–HSQC spectra were collected at 40, 43, 45, and 48 °C. The resi-
dues with temperature coefﬁcients b4.5 ppb/K were considered to
have hydrogen binding [38]. The observed 1H chemical shifts were
referenced to the DSS resonance at 0 ppm and the 15N and 13C chemical
shifts were indirectly referenced [39].
2.3. Size exclusion chromatography-multi-angle light scattering
(SEC-MALS) analysis
The molar masses of the protein-detergent complexes were deter-
mined using size exclusion chromatography (Superdex 200 10/300,
GE Healthcare) coupled with multi-angle light scattering (HELEOS,
Wyatt Technology), UV (Agilent 1100 Series; Agilent Technology),
and differential refractive index (Optilab rEX; Wyatt Technology)
detection. The measurements were performed on the samples that
had been used for NMR in 10 mM sodium acetate pH 4.6, 100 mM
NaCl, 0.05% LDAO at a ﬂow rate of 0.5 mL/min at room temperature.
HELEOS calibration constants were determined in the same buffer
using chicken egg lysozyme (Affymetrix) as the standard. Light
scattering data was analyzed and the molar mass of the protein–
detergent complex was determined using ASTRA software (Wyatt
Technology) [40]. The conjugate analysis module of ASTRA was used
to differentiate contributions of the protein and detergent to the mo-
lecular weight of each complex. The speciﬁc refractive index (dn/dc)
values of 0.185 and 0.148 were used for the protein and LDAO deter-
gent, respectively [41]. The UV extinction coefﬁcients of α4 and β2
were calculated from their sequences. A measured UV extinction
coefﬁcient of 0.06 for a 1% solution at 280 nm was used for LDAO.
2.4. The Na+ ﬂux assay for functional measurements
The Na+ ﬂux assay, as measured by the reduction of Sodium
Green™ dye (Invitrogen, Carlsbad, CA) ﬂuorescence due to Na+
leaving the vesicles through open channels, is an effective way to
macroscopically assess activity of the α4β2 TM channels. We pre-
pared 25 mM vesicles with ~500 μM α4β2. The vesicles contained
egg phosphatidylcholine (PC)/phosphatidylglycerol (PG) in a 3:1
molar ratio and lipid biotinyl-cap-PE (1 mol%). Lipids dissolved
in chloroform were mixed with α4β2 and dried to a thin ﬁlm by
nitrogen gas. Residual organic solvent was removed by vacuum
overnight. The lipid–protein mixture was hydrated overnight at
42 °C with a buffer solution containing 20 mM Tris, 100 mM NaCl,
and 3 μM Sodium Green™ at pH 7.5. The vesicles were obtained by
multiple subsequent cycles of freeze/thaw and sonication. Sodium
Green™ dye outside the vesicles was removed by extensive dialysis.
The Na+ ﬂux assay was performed using an Olympus IX81 micro-
scope (Olympus America, Center Valley, PA), equipped with a Sutter
Lambda xenon exciter light source, various excitation and emission
ﬁlters, and an ORCA-ER digital camera. For each measurement, vesi-
cles containing α4β2 were added onto the streptavidin coated glass
slide. The image acquisition started before vesicles were washed
with a buffer solution (50 mM CaCl2 20 mM Tris at pH 7.5) to dilute
the extra-vesicle Na+ concentration. The resulting Na+ concentration
gradient drove Na+ out of the vesicles when channels were formed.
Consequently the ﬂuorescence intensity resulting from Sodium
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Green™ ﬂuorescence intensity within each cluster of vesicles was
recorded using the program In-vivo and analyzed by MetaMorph
(Molecular Devices, Sunnyvale, CA).
2.5. Data processing, analysis and structure calculations
NMR data were processed using NMRPipe 4.1 and NMRDraw 1.8
[42], and analyzed using Sparky 3.10 [43]. 1H, 15N, and 13C chemical
shift assignments for the TM domains of the AChR α4 and β2 subunits
were performed manually using the acquired NMR spectra. Initial
NOE cross-peak assignment was carried out manually and then
more cross-peaks were assigned using CYANA 2.1 [44]. For both
the α4 and β2 subunits, a total of 100 monomer structures were
calculated using CYANA 3.0 based on NOE and hydrogen-bonding
restraints, as well as Talos dihedral angle restraints derived from the
chemical shifts [45]. Restraints for α4 and β2 are shown in Tables
S1 and S2, respectively. Of these 100 structures, 30 with the lowest
target function underwent further reﬁnement using Cyana 3.0. A
ﬁnal bundle of 20 structures with the lowest target function was
analyzed using VMD [46] and Molmol [47]. Contact maps were used
for evaluating tertiary structures of individual subunits and comparing
tertiary structures of different proteins. Contact areas between resi-
dues were analyzed using the CMA component of the SPACE suite
[48]. Contact surface area was deﬁned as the area between two
atoms into which a solvent molecule cannot ﬁt.
The α4 and β2 structures with the smallest RMSDs from their
respective average structures were used for building pentameric
models. The MATLAB® programming environment was used to
input structure coordinates, perform coordinate transformations,
and save a pentamer model in PDB format. Individual structures of
α4 and β2 were ﬁrst oriented such that each helical axis of TM2
was parallel to the Z-axis. The helical axis of TM2 was determined
using only the backbone atoms of residues from 245 to 266 for α4
or 239 to 260 for β2. The structures were then duplicated to form
(α4)2(β2)3 and (α4)3(β2)2 pentamers, where the center of the
backbone atoms for each of the ﬁve TM2 helices was located on the
vertices of a ﬁve-fold symmetric pentagon. Orientations of the α4
and β2 subunits were adjusted to satisfy the NMR chemical shift
perturbation data, in which interacting residues between α4 and β2
were indicated. The pore lining residues (T248, S252, and V259) forFig. 1. 1H–15N TROSY–HSQC spectra of the transmembrane domain of the human n-acetylch
or β2 in 10 mM sodium acetate, 10 mM NaCl, and 60 mM LDAO at pH 4.7 and 45 °C. For cl
Supplementary Material.the α4 subunit were also set to be consistent with experimental
results from the substituted cysteine accessibility method [49]. We
constructed two pentameric models of α4β2 with 2:3 and 3:2 ratios
for α4 to β2. It is plausible that α4β2 in our sample preparation
was in both stoichiometries [50,51]. The pentameric structural
models were subjected to 2000 steps of steepest descent minimiza-
tion in NAMD 2.6 [52] with a 100 kcal/mol restraint on backbone
atoms. The pore radius proﬁles were obtained using the HOLE pro-
gram [53] with a step size of 0.2 Å along the pore axis.
3. Results and discussion
3.1. Structures of the TM domains of the α4 and β2 nAChR subtypes
Fig. 1 shows representative NMR spectra of the α4 and β2 TM
domains in the LDAO micelles. Well-resolved peaks in the spectra
for individual residues and sustained protein stability were achieved
only after intensively tweaking sample conditions. In addition to mu-
tating a few residues in the terminal and loop regions and choosing a
proper detergent, setting a proper molar ratio of detergent to protein
(D:P) is also critical for the quality of NMR spectra. We found that the
D:P affected the oligomeric state ofα4 or β2.When the D:P was lower
than 100, the number of resonance peaks in the α4 or β2 NMR spec-
tra decreased substantially (Fig. S2), indicating the formation of large
size aggregates. When the D:P was greater than 300, quality of the
NMR spectra worsened after a short time period, presumably due to
an unfavorable oligomeric state for α4 or β2. An optimal condition
for protein stability and NMR spectral quality is to have the D:P in
the range of 200–250. This condition has been used for acquiring
data reported here. The oligomeric state of α4 or β2 under this condi-
tion was determined using size exclusion chromatography coupled
with multi-angle light scattering (SEC-MALS). The average molar
mass of the α4 or β2 assemblies was obtained by differentiating the
contributions of protein and detergent to the molar mass of each
complex using the differential dn/dc and UV extinction coefﬁcients
for the protein and detergent (Fig. S3). The SEC-MALS data showed
that the TM domains of α4 or β2 formed homo-pentamers with an
average molar mass of 74.5 kDa and 75.2 kDa, respectively.
Structures of the TM domains for subunits α4 (PDB ID: 2LLY) and
β2 (PDB ID: 2LM2), as shown in Fig. 2, were determined based on con-
straints generated from NMR experiments. Details of constraints foroline receptor (A) α4 and (B) β2 subunits. The spectra were acquired with 0.25 mM α4
arity, the chemical shift assignment for each peak is omitted here but provided in the
Fig. 2. A bundle of the 20 lowest-energy NMR structures for (A) α4 (PDB ID: 2LLY) and (B) β2 (PDB ID: 2LM2). The color scheme varies gradually from red in (A) or blue in (B) for
TM1 to green for TM4. (C) Overlay of the representative structures of α4 (red) with β2 (blue). Details of the NMR structural restraints and statistics for the reﬁned structures are
provided in Supplementary Materials.
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structural calculations are provided in the supplemental materials
(Fig. S4, Tables S1 and S2). For each subunit type, there are obvious
structural characteristics of four helices. Sufﬁcient long-range NOE re-
straints between different TM helices were identiﬁed for generating
tertiary folding (Fig. S5). The backbone RMSD of the helical regions
among the 20 lowest energy structures for α4 or β2 is less than 1 Å.
Because of their high sequence homology (~88%), the α4 and β2 TM
domains share considerable structure similarity (Fig. 2C), and the
backbone RMSD of their helical regions is ~1.5 Å. Variations of helical
arrangement betweenα4 and β2 are small, as reﬂected in similar pat-
terns of residue contact maps of the two subunits (Fig. S6).
To evaluate how amembranemimetic environment affects folding
of the TM domains, we compared the β2 structure solved in LDAO
micelles (Fig. 2) with our β2 structure (PDB ID: 2KSR) determined
previously in the HFIP–water mixture [9]. Interestingly, the two β2
structures resembled each other, as shown in the superimposed struc-
tures and the overlapped contact maps in Fig. S7. The result suggests
that helix–helix packing forces dominate assembly of the β2 TM
domain. A notable difference between two ensembles of the β2 struc-
tures is the bending of the TM2 helix near the TM2–TM3 linker, which
was observed in the HFIP/water mixtures but not in LDAO. Such a
conformational difference may reﬂect differences in mimicking the
water/membrane interface between the HFIP–water mixtures and
the LDAO micelles.
We also compared the α4 and β2 NMR structures with the struc-
tures of GLIC, GluCl, and the α1 and β1 Torpedo nAChR (Figs. S6 and
S7). The helical length of the pore-lining TM2 in α4 and β2 resembles
that in the GLIC and GluCl structures [13,14,16], but is shorter than
that in the Torpedo nAChR structural model [12]. The c-terminus of
the TM2 helix in α4, β2, GLIC and GluCl ends a few residues before
the conserved proline in the TM2–TM3 linker. The same helical termi-
nation at the c-terminus of TM2was also found previously in different
membrane mimetic environments [9,54]. However, in the Torpedo
nAChR structural mode, the TM2 helix ends three residues after this
conserved proline. Another interesting observation is on the TM3–
TM4 linkers of these proteins. Only two or six residues link TM3 and
TM4 in GLIC or GluCl, respectively. On the other hand, the TM3–TM4
linker in the Torpedo or theα4β2 nAChR is a large intracellular domain
that often involves over a hundred residues. The TM3–TM4 linker in
the Torpedo nAChR shows a helical segment [12]. To have the proteinsize manageable for NMR, we removed the majority of the intracellu-
lar domain and kept only 18 residues (13 original loop residues and
an additional ﬁve consecutive glycine residues) for the TM3–TM4
linker in α4 and β2. The drastic variations in the number of the
TM3–TM4 linker residues among these proteins do not profoundly
alter the four helical bundle motifs of the TM domains, as shown in
Figs. S6 and S7. The structural resilience to modiﬁcation of the intra-
cellular region is in accord with observations that the GABAA and
5HT3 receptors were functional after the deletion of their intracellular
domains [23].3.2. Pentameric structure model of the α4β2 TM domain
To determine whether the TM domains of α4 and β2 interact with
each other and their oligomerization state in LDAO micelles, we per-
formed NMR and SEC-MALS measurements on mixtures ofα4 and β2.
To obtain a better resolution, only one subunit type in the α4β2
mixture was 15N or 13C-labeled for each NMR spectrum. In other
words, only one set of residues, either from α4 or β2 in the mixture,
was observed in a NMR spectrum. If there were no interactions
between α4 and β2, the NMR spectrum of the mixture would be the
same as the spectrum ofα4 or β2 alone. On the other hand, differences
between the NMR spectra of a single subunit type and the α4β2 mix-
ture are indicative of interactions between two different subunits. As
shown in the spectral overlay of α4 and the α4β2 mixture in Fig. 3A,
several residues of the α4 subunit were perturbed by the addition of
the unlabeled β2. Similarly, β2 was perturbed in the NMR spectra
when it was mixed with the unlabeled α4. Fully annotated spectra
for α4 in the presence of β2 or β2 in the presence of α4 are provided
in the supplementarymaterials (Figs. S8 and S9). These NMRdata sug-
gested that theα4 and β2 TM domains interacted with each other and
formed oligomers in LDAOmicelles. The oligomeric state of theα4 and
β2 TM domains in the NMR samples was determined using size exclu-
sion chromatography coupledwith SEC-MALS. As shown in Fig. 3B, the
average molar mass of the α4β2 oligomers across the elution peak is
74.6 kDa, which is virtually the same as the expected molar mass of
75 kDa for a pentamer of the α4 and β2 TM domains. The TM domain
of α4 or β2 alone also formed homo-pentamers (Fig. S3), though the
intact α4 or β2 subunits have not been found to form homo-
pentamers. These results suggest that without the extracellular
Fig. 3. (A) Overlay of 1H–15N TROSY–HSQC spectra of α4 in the absence (black) and
presence (green) of β2. Peaks circled in red showed changes in α4 chemical shift
after the addition of β2, signifying interactions between α4 and β2. A limited number
of residues experiencing changes in chemical shift suggested that the presence of
β2 did not signiﬁcantly alter the α4 structure. (B) Size exclusion chromatography-
multi-angle light scattering analysis indicated the formation of the α4β2 pentameric
assembly. The molar mass (red) of the α4β2 assembly in the nAChR α4β2–detergent
complex was obtained using conjugate analysis and is shown across the elution peak
(black) from size exclusion chromatography. The average molar mass of the α4β2
assembly is 74.6 kDa. The dotted line indicates the expected molar mass of 75 kDa.
Fig. 4. Top views of the α4β2 pentamer models: (A) (α4)2(β2)3 and (B) (α4)3(β2)2.
Cartoon presentations forα4 and β2 subunits are colored orange and gray, respectively.
Residues of TM2 are shown in surface and colored according to residue types, acidic
in red, basic in blue, polar in green, and non-polar in white.
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semblies in a membrane mimetic environment.
Changes in the α4 and β2 NMR spectra due to a perturbation from
their interacting partners are relatively small and limited to only a
few residues (Fig. 3A, Figs. S8 and S9). This is understandable for at
least two reasons. First, the pure or mixed subunits are in the same
oligomeric state. Second, the α4 and β2 TM domains contain a high
percentage of identical residues. Because of these reasons, when the
adjacent subunit was changed from the same type to a different
type in the pentameric assemblies, the structure of the α4 or β2 sub-
unit did not change considerably. Thus, we built the α4β2 pentameric
models using the NMR subunit structures (Fig. 2). The NMR chemical
shift perturbation data (Figs. S8 and S9) were used to guide spatialarrangement of interacting residues between α4 and β2 for building
the model. For example, α4-L239 in the TM1 helix and β2-L294 in
the TM3 helix were both affected by the presence of the complemen-
tary subunit in the chemical shift perturbation experiments. They
are likely close to each other in space. Similar inter-subunit pairs
were identiﬁed at different locations along the membrane normal
(Fig. S10). They were used for assembling pentameric models.
The α4β2 nAChR was originally found to exist in the (α4)2(β2)3
stoichiometry [55,56], but later was also found to form (α4)3(β2)2
[50,51]. Thus, we constructed two models for both stoichiometries
(Fig. 4). The pore lining residues, T2′, S6′, L9′, V13′, L17′, and α4-
E20′ or β2-K20′, agree with those determined previously using the
substituted cysteine accessibility method (SCAM) [49,57]. The pore
radius proﬁles in Fig. 5 show funnel shaped channels for (α4)2(β2)3
and (α4)3(β2)2, openingwidely at the extracellular end and narrowing
gradually toward the intracellular end. The funnel shaped pore proﬁle
with a widely opened extracellular end was also observed in the
GLIC and GluCl structures, where both channels were concluded as
open channels [13,14,16]. The (α4)2(β2)3 model is in an apparent
open-channel conformation and its minimal pore radius at T2′ (2.9 Å)
is greater than that in GLIC (~2.5 Å). Although pore proﬁles resulting
from backbones are nearly the same for both models, the pore radius
Fig. 5. Pore-radius proﬁles for the (α4)2(β2)3 (black) and (α4)3(β2)2 (gray) models
determined by the backbone atoms (solid line) or including the side chains (dashed
line). Positions of the pore lining residues are highlighted. Pore proﬁles were generated
using the HOLE program [53].
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protruded to the pore lumen slightly more than that in β2.
The α4β2 nAChR structural model analyses indicate that hydro-
phobic contact is the driving force to assemble the TM domains
into a pentamer (Fig. S11). Leucine–isoleucine contacts (39%) and
leucine–leucine contacts (31%) are the major residue contacts
between two subunits. Other hydrophobic residues, including valine
and methionine, contribute 22% to the inter-subunit residue contacts.
There is only one pair of aromatic contacts (F298–Y232) between α4
and β2 subunits. The importance of hydrophobic residues in the
pentameric assembly was also demonstrated in a recent NMR study
on phospholamban [58]. The interlocking of alternating leucine and
isoleucine residues forms a leucine/isoleucine zipper to hold the
phospholamban protomers [58].
The α4β2 nAChR structural models allow us to visualize ﬁndings
implicated in previous experiments. Changing the stoichiometry of
α4 and β2 altered Ca2+ permeability in α4β2 nAChR. Increasing
the proportion of negative charges in (α4)3(β2)2 was found to asso-
ciate with increasing permeability to Ca2+ [59]. Indeed, as shown inFig. 6. Fluorescence images of the Na+ ﬂux assay on vesicles in the (A) presence and (B) a
Sodium Green™ ﬂuorescent dyes were enclosed and trapped inside the vesicles to probe i
channels in (A) decreased signiﬁcantly within a short period of time after washing away ex
intensity of the control vesicles without α4β2 in (B) remained nearly constant before andFig. 4, positively charged β2-K20′ and negatively charged α4-E20′
are located at the extracellular pore entrance. A larger proportion of
α4-E20′ in (α4)3(β2)2 provides a beneﬁt by attracting Ca2+ to the
pore entrance. Electrostatic interaction between β2-K20′ and α4-
E20′ may also help to stabilize pentameric assemblies [60]. Results
from previous photoafﬁnity labeling experiments on the α4β2
nAChR are well presented in, and explained by, our structural models.
[125I]TID, a hydrophobic probe [61], was photolabeled onto the α4β2
nAChR for mapping the protein/lipid interface [62]. We highlighted
the residues labeled by [125I]TID in our α4β2 models (Fig. S12),
including homologous residues α4-C582 and β2-C445 in TM4, α4-
C226 and α4-C231 in TM1, and β2-C220 that is homologous to α4-
C226 [62]. Clearly, our structures show exposure of α4-C582 and
β2-C445 in TM4 and α4-C231 in TM1 to lipids. More interestingly,
our structures show that α4-C582 and β2-C445 of TM4 face to α4-
C226 and β2-C220 of TM1, respectively. They form a [125I]TID binding
pocket along with surrounding lipids. Although α4-C226 and β2-
C220 are less exposed to lipids, their labeling by [125I]TID could be
facilitated by α4-C582 and β2-C445 in the same pockets. However,
if the Torpedo nAChR model [12] is used for explaining the photola-
beling data, α4-C582 and β2-C445 seem to have no association with
α4-C226 and β2-C220, respectively (Fig. S12).
3.3. Functional measurements of the α4β2 assembly
NMR chemical shift perturbation experiments in combination
with the SEC-MALS analysis provided evidence for the formation of
the α4β2 pentameric assembly. In order to assess whether the α4β2
TM domains formed channels, we reconstituted α4 and β2 into lipid
vesicles and performed the Na+ ﬂux assay. Signiﬁcant reduction of
Sodium Green™ dye ﬂuorescence was observed in vesicles immedi-
ately after dilution of the extra-vesicle salt concentration only if the
vesicles contained theα4β2 assembly (Fig. 6A). During the samemea-
surement time, however, ﬂuorescence remained almost the same in
vesicles lacking α4β2 (Fig. 6B), conﬁrming that the observed ﬂuores-
cence reduction in Fig. 6A was not due to ﬂuorescence bleaching.
Efﬂux of Na+ from the α4β2 containing vesicles is a compelling indi-
cation that the α4β2 TM domains are capable of forming channels
transporting Na+ across a membrane. The data in Fig. 6 suggest that
the open conformation of the α4β2 assembly is thermodynamicallybsence of the α4β2 nAChR channels at different time points. Membrane-impermeable
ntra-vesicle Na+ concentrations. The ﬂuorescence intensity of the vesicles with α4β2
tra-vesicle sodium, indicating Na+ efﬂux through the channels. However, ﬂuorescence
after washing away extra-vesicle Na+ during the same time period.
1267V. Bondarenko et al. / Biochimica et Biophysica Acta 1818 (2012) 1261–1268accessible at room temperature, though it cannot tell how rapidly the
closed and open conformations exchange spontaneously.
4. Conclusions
The study has delivered several novel ﬁndings. First, the atomic
structures of the whole TM domains of the α4 and β2 nAChR subunits
are solved for the ﬁrst time in micelles by using NMR. These struc-
tures are valuable for understanding the biological and pharmacolog-
ical properties of the α4β2 nAChR, particularly for characterizing
mechanisms of action for existing drugs and indentifying plausible
binding sites for new drugs. The methodology reported here for
achieving high quality NMR spectra of transmembrane proteins is
also useful for structural studies of other membrane proteins. Second,
our SEC-MALS data provided compelling evidence for a pentameric
oligomerization state of the TM domains of α4 and β2 as well as
their mixtures under the NMR sample condition. The NMR results
showed that hydrophobic interaction was the primary driving force
for oligomerization of individual subunits. Third, the TM domains
of α4 and β2 formed not merely pentameric assemblies. They are
ion channels permeable to Na+. Collectively, the study provides
structural insight into the TM domains of the α4β2 nAChR. It offers
a valuable structural framework for rationalizing extensive biochem-
ical data collected previously on the α4β2 nAChR and for designing
new therapeutic modulators.
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